Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks buoyed by China factory PMI, US-China trade news

Mon, 01st Apr 2019 08:35

(Sharecast News) - Stocks are kicking-off the new quarter on the front foot, helped by stronger-than-expected economic data out of the People's Republic of China and further positive news on the state of US-China trade talks.But ahead of another round of indicative votes in the British Parliament, later on Monday, on possible alternatives to the Prime Minister's proposed withdrawal agreement, a warning from Easyjet reminded investors of the toll that uncertainty surrounding the UK's exit from the European Union was taking on companies, as did another weak reading on German factory activity.In a statement, Easyet said: "Macroeconomic uncertainty and many unanswered questions surrounding Brexit are together driving weaker customer demand."As of 0835 GMT the FTSE 100 was ahead by 0.82% to 7,338.90. In parallel, front month Brent crude oil futures were adding 1.3% to $68.48 a barrel on the ICE and the pound was rising 0.08% to 1.1629.Also out of China, ahead of vice premier Liu He's trip to Washington this week for another round of trade negotiations, Beijing said it would extend a freeze on retaliatory tariffs on US car exports and add the opioid fentanyl to a list of controlled substances.Against that backdrop, all eyes were on a round of global manufacturing data due out at the start of the week, as investors tried to gauge whether a bottom was about to fall into place for the sector, which in turn might signal greater strength in stockmarkets around the world - or not.On that note, readings on Chinese factory sector activity in March released overnight printed ahead of forecasts, although economists appeared somewhat unconvinced by the figures, telling clients that at least some further weakness might yet be on the cards.Survey compiler Caixin's Chinese manufacturing Purchasing Managers' Index for March printed at 50.8, versus a reading of just 49.5 for the month before and economists' forecasts for a reading of 50.0.Some market commentary was also highlighting the possibility that seasonal factors, tied to the timing of the Lunar New Year in 2019, might lie behind that strength.Commenting on the Caixin PMI, Julian Evans-Pritchard at Capital Economics said: "there is now a decent chance that growth in China may bottom out slightly earlier than we had previously anticipated. That said, we still think growth could weaken again in the near-term. The recent trajectory of credit growth still points to a slowdown in the coming months."Going the other way, IHS Markit's factory sector PMIs for Germany and France were both revised lower.For later in the session, investors will be focusing on two key economic reports out of the States, those on retail sales covering the month of February at 1330 GMT, followed by the ISM's manufacturing sector index for March at 1500 GMT.Also due out was a manufacturing sector PMI for the month of March in the UK at 0930 GMT.In broker note action, analysts at Berenberg revised their recommendation for shares of Royal Mail from 'sell' to 'hold'.Fasten your seatbelts: Easyjet eyes potential turbulence aheadEasyJet said uncertainty over Brexit and the economy made the budget airline more cautious on its outlook as the airline reported first-half trading in line with guidance. The FTSE 100 carrier expects to post a headline pre-tax loss of £275m for the six months to the end of March as revenue rises 7.3% to about £2.34bn. Airlines traditionally report losses for the winter months. Revenue per seat will be about 7.4% lower, which easyJet said was in line with guidance issued in January. Costs per seat rose about 1.4% as crew costs increased.Ferrexpo announced a further delay to its annual results to give more time for an independent review of the company's donations to the charity Blooming Land. The FTSE 250 miner said it would publish its 2018 results on or before 25 April. It had previously delayed publication from 20 March to 3 April. An independent committee is examining the company's donations to Blooming Land, a Ukrainian charity set up to coordinate Ferrexpo's corporate and social responsibility programme.Rio Tinto said iron ore shipments from Pilbara in Australia would be at the low end of guidance after a cyclone damaged a port used to transport the commodity. Production from Pilbara will be about 14m tonnes lower than expected in 2019, the FTSE 100 miner said. As a result shipments of iron ore from the region will be at the low end of its guidance of 338m to 350m tonnes.AstraZeneca announced on Monday that the US Food and Drug Administration (FDA) has granted 'Breakthrough Therapy Designation' (BTD) for the MEK 1/2 inhibitor and potential new medicine selumetinib, which it is developing alongside its partner Merck. The FTSE 100 pharmaceuticals giant said the designation was for the treatment of paediatric patients aged three years and older with neurofibromatosis type 1 symptomatic or progressive, inoperable plexiform neurofibromas, which it described as a rare, incurable genetic condition.Sports Direct has prepared a template letter for other shareholders in Debenhams to use as part of boss Mike Ashley's push to install himself as chief executive of the troubled department store group. Sports Direct said on Monday that it had been contacted by "a number" of other concerned shareholders in Debenhams, concerned they will see the value of their shares wiped out by Debenhams financial restructuring plans and "expressing their support" for Ashley's appointment as CEO there.Market MoversFTSE 100 (UKX) 7,339.01 0.82%FTSE 250 (MCX) 19,234.48 0.61%techMARK (TASX) 3,540.75 0.95%FTSE 100 - RisersAshtead Group (AHT) 1,916.50p 3.45%WPP (WPP) 837.20p 3.26%Melrose Industries (MRO) 188.15p 2.73%Glencore (GLEN) 325.75p 2.45%BHP Group (BHP) 1,892.00p 2.35%Johnson Matthey (JMAT) 3,210.00p 2.16%Rio Tinto (RIO) 4,554.50p 2.10%Evraz (EVR) 633.20p 2.06%Smith (DS) (SMDS) 342.80p 2.05%AstraZeneca (AZN) 6,261.00p 2.05%FTSE 100 - FallerseasyJet (EZJ) 1,036.50p -7.25%International Consolidated Airlines Group SA (CDI) (IAG) 504.04p -1.55%TUI AG Reg Shs (DI) (TUI) 727.20p -1.14%SSE (SSE) 1,177.00p -0.84%Severn Trent (SVT) 1,961.50p -0.73%Fresnillo (FRES) 865.80p -0.57%Kingfisher (KGF) 233.70p -0.47%Centrica (CNA) 113.78p -0.37%Associated British Foods (ABF) 2,431.00p -0.33%Admiral Group (ADM) 2,165.00p -0.23%FTSE 250 - RisersContour Global (GLO) 179.80p 4.17%Ferrexpo (FXPO) 257.35p 3.94%Babcock International Group (BAB) 509.80p 3.30%Amigo Holdings (AMGO) 186.00p 3.20%John Laing Group (JLG) 391.80p 3.11%Royal Mail (RMG) 245.68p 3.10%Premier Oil (PMO) 96.67p 2.90%Weir Group (WEIR) 1,601.00p 2.76%Ted Baker (TED) 1,600.00p 2.70%Investec (INVP) 454.10p 2.67%FTSE 250 - FallersStobart Group Ltd. (STOB) 146.19p -3.82%Wizz Air Holdings (WIZZ) 2,936.98p -2.43%TBC Bank Group (TBCG) 1,522.00p -1.42%Telecom Plus (TEP) 1,500.00p -1.32%Just Group (JUST) 60.50p -1.14%Kier Group (KIE) 359.40p -1.05%HICL Infrastructure (HICL) 154.50p -0.90%Inmarsat (ISAT) 550.20p -0.86%Civitas Social Housing (CSH) 95.24p -0.79%Savills (SVS) 897.50p -0.77%
More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.